Zobrazeno 1 - 3
of 3
pro vyhledávání: '"María Isabel Ruíz-Olmedo"'
Autor:
María Isabel Ruíz-Olmedo, Ana Gabriela Amador-Hernández, Luis Jesús García-Aguirre, Liz Janet Medina Reyes, Lucia Zambrano Tapia, Jorge González-Canudas, Araceli Guadalupe Medina-Nolasco, Yulia Romero-Antonio, Aarón Molina-Pérez
Publikováno v:
Trends in Medicine. 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76e4a634e0c2df4abc1e0204282dcc1e
https://doi.org/10.15761/tim.1000176
https://doi.org/10.15761/tim.1000176
Autor:
Rafael Nambo-Venegas, Berenice Palacios-González, Jaime Mas-Oliva, Ana Karen Aurioles-Amozurrutia, Armando Cruz-Rangel, Abel Moreno, Alfredo Hidalgo-Miranda, Mauricio Rodríguez-Dorantes, Felipe Vadillo-Ortega, Juan Xicohtencatl-Cortes, María Isabel Ruiz-Olmedo, Juan Pablo Reyes-Grajeda
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 490 (2023)
Background: M1 macrophages involved in pro-inflammatory processes can be induced by low-density lipoproteins (LDL), giving rise to foam cells. In the atheroma plaque, it has been identified that males present more advanced lesions associated with inf
Externí odkaz:
https://doaj.org/article/3c75f6023b884c8da776f222e9492961
Autor:
María Isabel Ruiz-Olmedo, Iliana González-Hernández, Francisca Palomares-Alonso, Javier Franco-Pérez, María de Lourdes González F., Helgi Jung-Cook
Publikováno v:
Saudi Pharmaceutical Journal, Vol 25, Iss 3, Pp 413-418 (2017)
Background: Although albendazole is the drug-of-choice for the treatment of neurocysticercosis, its efficacy is limited due to its low bioavailability. An alternative for optimizing pharmacological treatment is through drug combinations. In vitro stu
Externí odkaz:
https://doaj.org/article/a8d98bd1f67f4c8d863ea4a236f74d1b